GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
2,771
Funds Holding Change
+2
Funds Holding Growth
+0.1%
Value
$518B
Holding in Top 10
455
Top 10 Change
+7
Top 10 Growth
+2%
Value Growth
+5%
New
106
Increased
1,267
Reduced
1,187
Closed
77
Capital Inflow
$22.5B
Capital Outflow
$14.5B
Net Capital Flow
+$7.94B
Capital Flow Change
-$32B
Calls
$6.15B
Puts
$7.91B
Net Calls
-$1.76B
Put/Call Ratio
1.29